Effect of different hormone replacement therapy regimens on circadian blood pressure profile and active renin in postmenopausal women

References

• Mosca L, Manson JE, Sutherland SE, et al. Cardio-vascular disease in women: a statement for health-care professionals from the American Health Association Writing Group. Circulation 1997;96: 2468–82
   PubMed Web of Science ®Google Scholar
• ReckelhoffJF. Gender differences in the regulation of blood pressure. Hypertension 2001;37:1199–208
   PubMed Web of Science ®Google Scholar
• Staessen JA, Celis H, Fagard R. The epidemiology of the association between hypertension and menopause. J Hum Hypertens 1998;12:587–92
   PubMed Web of Science ®Google Scholar
• Mercuro G, Pitzalis L, Podda A, et al. Does the menopause play a role as a risk factor for essential hypertension? Circulation 1998;78:861–4
   Google Scholar
• Edmunds E, Lip GYH. Cardiovascular risk in women: the cardiologist's perspective. Q J Med 2000;93:135–45
   Google Scholar
• Grodstein F, Manson JE, Colditz GA, et al. A prospective, observational study ofpostmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000; 133:933–41
   PubMed Web of Science ®Google Scholar
• Van Baal WM, Kooistra T, Stehouwer CDA. Cardiovascular disease risk and hormone replace-ment therapy (HRT): a review based on random-ised, controlled studies in postmenopausal women. Curr Med Chem 2000;7:499–517
   Google Scholar
• Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus pro gestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replace-ment Study (HERS) Research Group. J Am Med Assoc 1998;280:605–13
   Web of Science ®Google Scholar
• Crane MG, Harris B. Estrogens and hypertension: effect of discontinuing estrogens on blo od pressure, exchangeable sodium, and renin-aldosterone system. Am J Med Sci 1978;276:33–55
   PubMed Web of Science ®Google Scholar
• Oelkers WK. Effects of estrogens and pro gestogens on the renin-aldosterone system and blood pressure. Steroids 1996;61:166–71
   PubMed Web of Science ®Google Scholar
• Harvey PJ, Wing LM, Savage J, Molloy D. The effects of different types and different doses of estrogen replacement therapy on clinic and ambu-latory blood pressure and the renin-angiotensin system in no rmotensive postmenopausal women. J Hypertens 1999;17:405–11
   PubMed Web of Science ®Google Scholar
• Scuteri A, Bos AJ, Brant U, et al. Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women. Ann Intern Med 2001;135:229–38
   PubMed Web of Science ®Google Scholar
• Akkad AA, Halligan AWF, Abrams K, Al-Azzawi F. Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy. Obstet Gynecol 1997;89: 97–103
   Google Scholar
• Butkevich A, Abraham C, Phillips RA. Hormone replacement therapy and 24-hour blood pressure profile of postmenopausal women. Am J Hypertens 2000;13: 1039–41
   Google Scholar
• Noto R, Rapisarda A, Mirabella C, et al. Blood pressure variations assessed by continuous 24-hour monitoring in menopausal and climacteric women. Eur Rev Med Pharmacol Sci 2000;4:25–30
   PubMedGoogle Scholar
• Verdecchia P, Schillaci G, Gatteschi C, et al. Blunted nocturnal fall in blood pressure in hyper-tensive women with future cardiovascular morbid events. Circulation 1993;88:986–92
   PubMed Web of Science ®Google Scholar
• Seely EW, Walsh BW, Gerhard MD, Williams GH. Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women. Hypertension 1999;33:1190–4
   PubMed Web of Science ®Google Scholar
• Wilson TW, Lacourciere Y, Barnes CC, for the Canadian Cozaar Hyzaar Amlodipine Trial Study Group. The antihypertensive efficacy of losartan and amlodipine assess ed with office and ambulatory blood pressure monitoring. Can Med AssocJ 1998; 159:469–76
   Google Scholar
• Zakopoulos NA, Nanas SN, Lekakis JP, et al. Reproducibility of ambulatory blood pressure measurements in essential hypertension. Blood Press Monit 2001;6:41–5
   PubMed Web of Science ®Google Scholar
• Neutel JM. The importance of 24-h blood pressure control. Blood Press Monit 2001;6:9–16
   PubMed Web of Science ®Google Scholar
• van de Borne P, Nguyen H, Biston P, et al. Effects of wake and sleep stages on the 24-h autonomic control of blood pressure and heart rate in recum-bent men. Am J Physiol 1994;266:H548—H554
   Google Scholar
• Guthrie JR, Dennerstein L, Dudley EC. Weight gain and the menopause: a 5-year prospective study. Climacteric 1999;2: 205–11
   Google Scholar
• Chmouliovsky L, Habicht F, James RW, et al. Beneficial effect of hormone replacement therapy on weight loss in obese menopausal women. Maturitas 1999;16:147–53
   Google Scholar
• Brosnihan KB, Senanayake PS, Li P, Ferrario CM. Bi-directional actions of estrogen on the renin-angiotensin system. Braz J Med Biol Res 1999;32: 373–81
   PubMed Web of Science ®Google Scholar
• Brosnihan KB, Weddle D, Antony MS, et al. Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys. J Hypertens 1997;15:719–26
   PubMed Web of Science ®Google Scholar
• Schunkert H, Jan Danser AH, Hense HW, et al. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 1997;95:39–45
   PubMed Web of Science ®Google Scholar
• Umeda M, Ichikawa S, Kanda T, et al. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women. Am J Hypertens 2001;14:206–11
   PubMed Web of Science ®Google Scholar
• Derkx FHM, deBruin RJA, Gool JMGV, et al. Clinical validation of monoclonal renin antibody sandwich assays of renin and prorenin. Clin Chem 1996;42:1051–63
   PubMed Web of Science ®Google Scholar
• Seed M. Sex hormones, lipoproteins and cardio-vascular risk. Atherosclerosis 1991;90:1–7
   PubMed Web of Science ®Google Scholar
• The Writing Group for the PEPI Trial. Effect of estrogen/progestin regimens on heart disease risk factors in postmenopausal women.J Am Med Assoc 1995;273:199–208
   PubMed Web of Science ®Google Scholar
• Paganini-Hill A, Dworsky R, Krauss RM. Hor-mone replacement therapy, hormone levels, and lipoprotein cholesterol concentration in elderly women. Obstet Gynecol 1996;174:897–902
   Google Scholar
• Farish E, Spowart K, Barnes JF, et al. Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions. Atherosclerosis 1996;126:77–84
   PubMed Web of Science ®Google Scholar
• Marchien van Baal W, Kooistra T, Stehouwer DA. Cardiovascular disease risk and hormone replace-ment therapy (HRT): a review based on random-ized, controlled studies in postmenopausalwomen. Cur Med Chem 2000;7:499–517
   PubMed Web of Science ®Google Scholar
• Nasr A, Breckwoldt M. Estrogen replacement therapy and cardiovascular protection: lipid mechanisms are the tip of an iceberg. Gynecol Endocrinol 1998;12:43–59
   PubMed Web of Science ®Google Scholar